Pharmaceuticals - Community Register

  

Community register of medicinal products for human use


AUTHORISED  

Product information

Invented name: JETREA   
Auth. number : EU/1/13/819
INN : OCRIPLASMIN
ATC: Pending
Indication: JETREA is indicated in adults for the treatment of vitreomacular traction (VMT), including when associated with macular hole of diameter less than or equal to 400 microns
Marketing Authorisation Holder: ThromboGenics NV
Gaston Geenslaan 1, B-3001 Leuven, België

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/03/2013 Centralised - Authorisation EMEA/H/C/2381 (2013)1648 of 13/03/2013
11/11/2013 Centralised - Variation EMEA/H/C/2381/IA/4/G
13/02/2014 Centralised - Variation EMEA/H/C/2381/N/9
20/03/2014 Centralised - Variation EMEA/H/C/2381/II/7